Porcine induced pluripotent stem cells (piPSC) for expanding the use of swine in biomedical research by Ezashi, Toshihiko et al.
Porcine induced pluripotent stem cells (piPSC) for expanding the use 
of swine in biomedical research 
 
Toshihiko Ezashi1, Bhanu Prakash V.L. Telugu1 and R. Michael Roberts1,2 
1Division of Animal Sciences; 2Department of Biochemistry, University of Missouri, Columbia, MO, 
USA. 
 
Our goal is to create porcine pluripotent stem cells, i.e. ones capable of 
differentiating into all cell types of the body that can expand the use of swine as a 
biomedical model for studying human disease. It is well established that mouse 
embryonic stem cells (ESC) are an excellent source of material for successful 
cloning and for incorporation into chimeras. However, the establishment of porcine 
ESC from the embryos has proven to be elusive. There has been a similar lack of 
success with other ungulate species. Establishing a technology for deriving 
induced pluripotent stem cells (iPSC) from farm animals will allow the gene knock-
in/knock-out methods that have revolutionized mouse genetics to be applied to 
farm species. Importantly pig is a potentially useful model for studying human 
pathologies due to similarities in organ size, immunology and whole animal 
physiology between the two species. If the safety and efficacy of stem cell 
transplantation is to be tested in an animal model before being applied to humans, 
the pig would likely be a species of choice. The ability to derive porcine (p) iPSC 
lines from a particular outbred animal and conduct tissue transplantation on the 
same pig later and follow the success of the transplant over the course of months 
or even years would be a particularly valuable advance. Additionally the ability to 
provide piPSC from animals with valuable traits would provide a permanent source 
of cells for clonal propagation that would likely avoid the inefficiencies and 
problems arising from somatic cell nuclear transfer (SCNT), where the vast 
majority of cloned offspring die or are developmentally abnormal. We have created 
piPSC from embryonic fibroblasts and umbilical cord mesenchyme by a similar 
strategy used for the mouse and human, namely ectopically expressing 
reprogramming genes in somatic cells. The piPSC resemble human ESC, express 
the typical gene and surface antigen markers of ESC, proliferate continuously in 
culture, possess high telomerase activity, form embryoid bodies, and differentiate 
along the three main germ line lineages. Our aim is to demonstrate that piPSC can 
be directed to differentiate along defined lineages, specifically towards neuronal 
tissue, hematopoietic lineages and various mesoderm derivatives including 
cardiomyocytes by using protocols based on those used successfully with human 
and murine ESC. These experiments will allow such cells to be used for tissue 
grafts that are matched genetically to recipients and tested for their safety in 
transplantation. We shall also establish parameters for routine gene targeting in 
piPSC, with the ultimate goal of creating genetic models for human diseases where 
mouse models are inappropriate. In summary, the piPSC lines developed will have 
enormous utility for exploiting the pig as a model in human pre-clinical applications. 
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